Distinguished in Stomach Cancer

Changming P. Huang

Fujian Medical University Union Hospital
Fuzhou, CN 
Distinguished in Stomach Cancer
Fujian Medical University Union Hospital
Fuzhou, CN 
OverviewLocationsClinical Research

Overview

Changming Huang practices in Fuzhou, China. Huang is rated as a Distinguished expert by MediFind in the treatment of Stomach Cancer. Their top areas of expertise are Stomach Cancer, Adenocarcinoid Tumor, Gastrointestinal Stromal Tumor, Gastrectomy, and Endoscopy.

Their clinical research consists of co-authoring 60 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 53 articles and participated in 3 clinical trials in the study of Stomach Cancer.

Locations

Fujian Medical University Union Hospital
Fuzhou, China
Other Locations
Department Of Otorhinolaryngology Head And Neck Surgery, Beijing, 100054, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy- A Prospective Cohort Study
The Effect of Preoperative Hemotologic Markers on Postoperative Long-term and Short-term Outcomes for Laparoscopic Gastrectomy- A Prospective Cohort Study
Enrollment Status: Unknown
Publish Date: February 05, 2020
Safety and Feasibility of Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Locally Advanced Upper Third Gastric Cancer: A Multicenter Phase II Trial
Safety and Feasibility of Laparoscopic Spleen-Preserving No. 10 Lymph Node Dissection for Locally Advanced Upper Third Gastric Cancer: A Multicenter Phase II Trial
Enrollment Status: Unknown
Publish Date: February 05, 2020
Intervention Type: Drug, Procedure
Study Drug: Oxaliplatin
Study Phase: Phase 2
The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy- A Prospective Cohort Study
The Effect of Preoperative Inflammation-based Scores on Postoperative Morbidity and Mortality for Laparoscopic Gastrectomy- A Prospective Cohort Study
Enrollment Status: Unknown
Publish Date: February 05, 2020
View 2 Less Clinical Trials

60 Total Publications

Long-term survival outcomes of laparoscopic total gastrectomy vs open total gastrectomy in patients with clinical stage I gastric cancer the CLASS02 randomized clinical trial.
Long-term survival outcomes of laparoscopic total gastrectomy vs open total gastrectomy in patients with clinical stage I gastric cancer the CLASS02 randomized clinical trial.
Journal: International journal of surgery (London, England)
Published: August 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Huang's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile